Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pCLXSN-c-JUN Citations (2)

Originally described in: JNK signaling mediates EPHA2-dependent tumor cell proliferation, motility, and cancer stem cell-like properties in non-small cell lung cancer.
Song W, Ma Y, Wang J, Brantley-Sieders D, Chen J Cancer Res. 2014 May 1;74(9):2444-54. doi: 10.1158/0008-5472.CAN-13-2136. Epub 2014 Mar 7. PubMed Journal

Articles Citing pCLXSN-c-JUN

Articles
The CDK4/6-EZH2 pathway is a potential therapeutic target for psoriasis. Muller A, Dickmanns A, Resch C, Schakel K, Hailfinger S, Dobbelstein M, Schulze-Osthoff K, Kramer D. J Clin Invest. 2020 Jul 23. pii: 134217. doi: 10.1172/JCI134217. PubMed
Targeting KDM4A epigenetically activates tumor-cell-intrinsic immunity by inducing DNA replication stress. Zhang W, Liu W, Jia L, Chen D, Chang I, Lake M, Bentolila LA, Wang CY. Mol Cell. 2021 May 20;81(10):2148-2165.e9. doi: 10.1016/j.molcel.2021.02.038. Epub 2021 Mar 19. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.